To include your compound in the COVID-19 Resource Center, submit it here.

LibiGel testosterone: Complete Phase III enrollment

BioSante completed enrollment of over 3,550 patients in its double-blind, placebo-controlled, international

Read the full 129 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE